NEW ORLEANS--(BUSINESS WIRE)--Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from OraglutideTM — small capsule intestinally-released oral semaglutide, formulated using the proprietary AxcessTM delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of OraglutideTM produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest d